Refusal of Inspection by a Foreign Food Establishment or Foreign Government; Guidance for Industry; Availability, 64054-64055 [2022-22884]
Download as PDF
64054
Federal Register / Vol. 87, No. 203 / Friday, October 21, 2022 / Notices
reports, and inform policy and program
development that is responsive to the
needs of victims.
The information collection captures
information on participant
demographics (e.g., age, gender identity,
race/ethnicity, country of origin), type
of trafficking experienced (sex, labor, or
both), types of services and benefits
provided, along with aggregate
information on the amount of money
spent on each type of service provided,
outreach activities conducted,
subrecipients enrolled, and the types of
trainings provided to relevant
audiences. Minor updates have been
made to performance indicators under
this collection in consultation with
existing grant recipients and
stakeholders, to reduce respondent
burden, strengthen client privacy and
confidentiality, and to bring the
collection into alignment with program
requirements under the revised TVAP.
Specifically, to reduce burden and
strengthen client privacy and
confidentiality, the following TVAP
client-level indicators have been
removed: Type of Intake, Date of Birth,
Services Requested at Intake, Benefits
Requested at Intake, Trafficker
Relationship to Victim, and
Employment Status at Case Closure. To
reduce respondent burden, additional
proposed outreach and subrecipient
indicators have also been removed:
Screening Tool Used During Outreach,
Goal of Subrecipient Partnership, Type
of Subrecipient Partnership; Services
Provided by Subrecipient (In-House)
and Services Provided by Subrecipient
(by Referral) have been collapsed into
one category: Services Provided By
Subrecipient. To bring the collection
into alignment with the revised TVAP
requirements, outreach-specific
indicators have been added,
specifically: Number of Outreach
Activities Conducted, Date of Outreach
Activity, Outreach Settings, Target
Population(s), Number of Victims
Identified. The TVAP Spending Form
was renamed to Categories of Assistance
and categories have been simplified to
reduce reporting burden.
Respondents: TVAP Grant Recipients
and Clients of those programs,
specifically the: TVAP (HHS–2022–
ACF–IOAS–OTIP–ZV–0150), Aspire:
Child Trafficking Victim Assistance
Demonstration Program (HHS–2022–
ACF–IOAS–OTIP–TV–0099), Victims of
Human Trafficking Services and
Outreach Program—Pacific Region
Demonstration Program (VHT–SO
Pacific) (HHS–2022–ACF–IOAS–OTIP–
ZV–0038) and the Lighthouse: Services,
Outreach, and Awareness for Labor
Trafficking (Lighthouse) Demonstration
Program (HHS–2022–ACF–IOAS–OTIP–
ZV–0059).
ANNUAL BURDEN ESTIMATES
Total number
of respondents
Instrument
Client Characteristics and Program Entry ...........................
Client Case Closure .............................................................
Barriers to Service Delivery and Monitoring ........................
Client Service Use and Delivery ..........................................
Victim Outreach ...................................................................
Training ................................................................................
Subrecipient Enrollment .......................................................
Categories of Assistance .....................................................
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2022–22842 Filed 10–20–22; 8:45 am]
BILLING CODE 4184–47–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2017–D–6528]
jspears on DSK121TN23PROD with NOTICES
Refusal of Inspection by a Foreign
Food Establishment or Foreign
Government; Guidance for Industry;
Availability
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or we) is
announcing the availability of a final
guidance for industry entitled ‘‘Refusal
SUMMARY:
VerDate Sep<11>2014
19:08 Oct 20, 2022
Jkt 259001
6600
6600
386
6600
386
386
193
193
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Average
burden hours
per response
1
1
4
1
4
4
2
1
of Inspection by a Foreign Food
Establishment or Foreign Government.’’
The guidance will provide information
for foreign food establishments subject
to our inspection, as well as foreign
governments, on when we may consider
that a foreign food establishment or a
government of a foreign country has
refused to permit an inspection by us as
provided in the Federal Food, Drug, and
Cosmetic Act (FD&C Act).
DATES: The announcement of the
guidance is published in the Federal
Register on October 21, 2022.
ADDRESSES: You may submit either
electronic or written comments on
Agency guidances at any time as
follows:
Estimated Total Annual Burden
Hours: 3118.75.
Authority: 22 U.S.C. 7105.
AGENCY:
Total number
of responses
per
respondent
0.75
0.167
0.167
0.25
0.3
0.5
0.167
0.5
Total burden
hours
4950
1102.2
257.85
1650
463.2
772
64.5
96.5
Annual burden
hours
1650
367.4
85.95
550
154.4
257.3
21.5
32.2
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
E:\FR\FM\21OCN1.SGM
21OCN1
jspears on DSK121TN23PROD with NOTICES
Federal Register / Vol. 87, No. 203 / Friday, October 21, 2022 / Notices
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2017–D–6528 for ‘‘Refusal of Inspection
by a Foreign Food Establishment or
Foreign Government.’’ Received
comments will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
VerDate Sep<11>2014
19:08 Oct 20, 2022
Jkt 259001
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of the guidance to the
Compliance Policy Staff/Office of
Compliance, Center for Food Safety and
Applied Nutrition (HFS–605), Food and
Drug Administration, 5001 Campus Dr.,
College Park, MD 20740. Send two selfaddressed adhesive labels to assist that
office in processing your request. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the guidance.
FOR FURTHER INFORMATION CONTACT:
Yinqing Ma, Center for Food Safety and
Applied Nutrition (HFS–605), Food and
Drug Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–2479.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the availability of
a guidance for industry entitled
‘‘Refusal of Inspection by a Foreign
Food Establishment or Foreign
Government.’’ We are issuing this
guidance consistent with our good
guidance practices regulation (21 CFR
10.115). The guidance represents the
current thinking of FDA on this topic.
It does not establish any rights for any
person and is not binding on FDA or the
public. You can use an alternative
approach if it satisfies the requirements
of the applicable statutes and
regulations.
In the Federal Register of December
12, 2017 (82 FR 58410), we made
available a draft guidance for industry
entitled ‘‘Refusal of Inspection by a
Foreign Food Establishment or Foreign
Government’’ and gave interested
parties an opportunity to submit
comments by February 26, 2018, for us
to consider before beginning work on
the final version of the guidance. We
received several comments on the draft
guidance and have modified the final
guidance where appropriate. Changes to
the guidance include: provided
additional information on FDA’s
inspection authority; clarified that the
investigator will inform the owner,
operator, or agent in charge of the
establishment when they consider their
action to be a refusal and will explain
the consequences of the refusal; and
clarified that the Agency will make the
final decision regarding refusal and
listing on Import Alert 99–32. In
addition, we made editorial changes to
improve clarity. The guidance
announced in this notice finalizes the
draft guidance dated December 2017.
II. Electronic Access
Persons with access to the internet
may obtain the guidance at either
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
64055
https://www.fda.gov/FoodGuidances or
https://www.regulations.gov. Use the
FDA website listed in the previous
sentence to find the most current
version of the guidance.
Dated: October 17, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–22884 Filed 10–20–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA 2016–D–4460]
Multiple Endpoints in Clinical Trials;
Guidance for Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a final
guidance for industry entitled ‘‘Multiple
Endpoints in Clinical Trials.’’ This
guidance provides sponsors and review
staff with the Agency’s thinking about
the problems posed by multiple
endpoints in the analysis and
interpretation of study results and how
these problems can be managed in
clinical trials for human drugs,
including drugs subject to licensing as
biological products. This guidance
finalizes the draft guidance of the same
title issued on January 13, 2017.
DATES: The announcement of the
guidance is published in the Federal
Register on October 21, 2022.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
E:\FR\FM\21OCN1.SGM
21OCN1
Agencies
[Federal Register Volume 87, Number 203 (Friday, October 21, 2022)]
[Notices]
[Pages 64054-64055]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22884]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2017-D-6528]
Refusal of Inspection by a Foreign Food Establishment or Foreign
Government; Guidance for Industry; Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of availability.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing the
availability of a final guidance for industry entitled ``Refusal of
Inspection by a Foreign Food Establishment or Foreign Government.'' The
guidance will provide information for foreign food establishments
subject to our inspection, as well as foreign governments, on when we
may consider that a foreign food establishment or a government of a
foreign country has refused to permit an inspection by us as provided
in the Federal Food, Drug, and Cosmetic Act (FD&C Act).
DATES: The announcement of the guidance is published in the Federal
Register on October 21, 2022.
ADDRESSES: You may submit either electronic or written comments on
Agency guidances at any time as follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Dockets
[[Page 64055]]
Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2017-D-6528 for ``Refusal of Inspection by a Foreign Food
Establishment or Foreign Government.'' Received comments will be placed
in the docket and, except for those submitted as ``Confidential
Submissions,'' publicly viewable at https://www.regulations.gov or at
the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through
Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
You may submit comments on any guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single copies of the guidance to the
Compliance Policy Staff/Office of Compliance, Center for Food Safety
and Applied Nutrition (HFS-605), Food and Drug Administration, 5001
Campus Dr., College Park, MD 20740. Send two self-addressed adhesive
labels to assist that office in processing your request. See the
SUPPLEMENTARY INFORMATION section for electronic access to the
guidance.
FOR FURTHER INFORMATION CONTACT: Yinqing Ma, Center for Food Safety and
Applied Nutrition (HFS-605), Food and Drug Administration, 5001 Campus
Dr., College Park, MD 20740, 240-402-2479.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the availability of a guidance for industry
entitled ``Refusal of Inspection by a Foreign Food Establishment or
Foreign Government.'' We are issuing this guidance consistent with our
good guidance practices regulation (21 CFR 10.115). The guidance
represents the current thinking of FDA on this topic. It does not
establish any rights for any person and is not binding on FDA or the
public. You can use an alternative approach if it satisfies the
requirements of the applicable statutes and regulations.
In the Federal Register of December 12, 2017 (82 FR 58410), we made
available a draft guidance for industry entitled ``Refusal of
Inspection by a Foreign Food Establishment or Foreign Government'' and
gave interested parties an opportunity to submit comments by February
26, 2018, for us to consider before beginning work on the final version
of the guidance. We received several comments on the draft guidance and
have modified the final guidance where appropriate. Changes to the
guidance include: provided additional information on FDA's inspection
authority; clarified that the investigator will inform the owner,
operator, or agent in charge of the establishment when they consider
their action to be a refusal and will explain the consequences of the
refusal; and clarified that the Agency will make the final decision
regarding refusal and listing on Import Alert 99-32. In addition, we
made editorial changes to improve clarity. The guidance announced in
this notice finalizes the draft guidance dated December 2017.
II. Electronic Access
Persons with access to the internet may obtain the guidance at
either https://www.fda.gov/FoodGuidances or https://www.regulations.gov. Use the FDA website listed in the previous
sentence to find the most current version of the guidance.
Dated: October 17, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-22884 Filed 10-20-22; 8:45 am]
BILLING CODE 4164-01-P